K-numberK253593
Device nameClarius Ejection Fraction AI
ApplicantClarius Mobile Health Corp.
Product codeQIH
Device classClass II
Decision dateMar 2, 2026
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Clarius Ejection Fraction AI is a machine learning algorithm integrated into the Clarius App software that uses deep learning to automatically measure left ventricular ejection fraction from ultrasound images acquired by Clarius ultrasound scanners. It is intended for semi-automatic, non-invasive measurement of cardiac function in adult patients, with trained healthcare professionals retaining responsibility for validating measurements based on clinical judgment.

Technological characteristics

Both the subject device and predicate device employ ultrasound image processing software using artificial intelligence/machine learning algorithms trained on clinical and/or artificial data for detection, segmentation, and measurement of left ventricular ejection fraction. Both support segmentation of cardiac anatomy, automated measurement calculation, and manual adjustment capability. Both are non-adaptive machine learning systems intended for professional healthcare settings with licensed users.

Test standards cited

IEC 62304:2006 + A1:2015 (medical device software life cycle processes), ISO 14971:2019 (risk management), IEC 62366-1:2015 + A1:2020 (usability engineering), and ISO 15223-1:2021 (medical device symbols and labeling).

Substantial equivalence argument

Clarius Ejection Fraction AI is substantially equivalent to Caption Interpretation Automated Ejection Fraction Software (K210747) because both devices employ identical regulatory classifications, principles of operation, and AI/ML algorithmic approaches for left ventricular ejection fraction measurement. Clinical verification testing demonstrated Clarius EF measurements are non-inferior to expert clinician measurements with statistically significant p-values across multiple cardiac views, and the device performs as intended for semi-automated cardiac ultrasound applications.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →